<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/250276-polymeric-adhesive-matrix-with-salified-carboxylic-groups-for-transdermal-use by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 14:31:41 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 250276:POLYMERIC ADHESIVE MATRIX WITH SALIFIED CARBOXYLIC GROUPS FOR TRANSDERMAL USE</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">POLYMERIC ADHESIVE MATRIX WITH SALIFIED CARBOXYLIC GROUPS FOR TRANSDERMAL USE</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>Polymeric matrices for the controlled release of medicaments for the topical transdermal use comprising copolymers of acrylic and/or methacrylic acid or esters thereof having a Tg lower than 0°C, whose free carboxy groups are salified with compatible organic or inorganic bases. The matrices of the invention allow to prepare therapeutical systems for the controlled-release of active principles through the transdermal route, thus solving stability, solubility and/or bioavailability problems of the active ingredient within the matrix.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>The present invention relates to a polymeric matrix for the<br>
conlrolled-release of medicaments for the topical transdermal use, which<br>
matrix improves the solubility and the stability of the active ingredient.<br>
Technological background<br>
Controlled-releasc therapeutical systems (based on a matrix) for the<br>
transdermal administration arc prepared by incorporation of an active<br>
ingredient (active principle) in a polymeric matrix, which acts both as<br>
adhesive and 'container" for the medicament.<br>
For this reason, a polymeric matrix must satisfy a series of specific<br>
requirements:<br>
• ability to dissolve (he active principle at the desired concentrations;<br>
• absence of chemical interactions with the active principle, so as to<br>
avoid degradation or alteration;<br>
• ability to allow the diffusion of the active principle towards the<br>
corneous layer;<br>
• absence of irritation or erythema at the application site;<br>
• ability to ensure adhesion of the system to the skin during the whole<br>
treatment period.<br>
The matrices arc made from solutions of adhesive polymers also<br>
referred to as "pressure sensitive adhesives".<br>
The most commonly used polymers are of acrylic type and are<br>
commercially available in the form of powders, granules, aqueous or solvent<br>
solutions.<br>
In general, the polymers used for pharmaceutical formulations belong to<br>
two classes, those with a glass transition temperature (Tg) higher than room<br>
temperature (or use temperature) and those with a Tg lower than room<br>
temperature. The former need plasticizers to be used in the formulation of<br>
transdermal patches, while the latter can be used as such, since they already<br>
have a soft consistency. For this reason, polymers with a Tg 
preferred, even if, due to their properties, they are commercialised dissolved<br>
in organic solvents.<br>
Many of these polymers are copolymers of acrylic or methacrylic acid<br>
and/or esters thereof, therefore the polymer chains contain acidic functions<br>
which can interact with the active principle causing oxidation and/or<br>
degradation of the active principle.<br>
U.S. 6,689,379 discloses transdermal therapeutic systems comprising a pressure-sensitive<br>
adhesive polymer having acrylic or methacrylic acid units in form of alkali or alkaline earth salts.<br>
FR 2719770 discloses transdermal formulations of ibuprofen comprising a mixture of<br>
acrylate copolymers and diethylphtalates.<br>
Other transdermal systems are disclosed in US 2003/0129220, US 2001/0038861, EP<br>
0394956, WO 03/086370, US 2004/010054.<br>
It has now been found that matrix-based therapeutical systems for the<br>
controlled release of medicaments can be prepared by suitably salifying the<br>
free carboxy groups of the polymer chains of macromolecules mixtures having<br>
a lower Tg.<br>
15 Disclosure of the invention<br>
The invention relates to a polymeric matrix for the controlled release of<br>
medicaments for the topical transdermal use, which matrix comprises<br>
copolymers of acrylic or methacrylic acid and/or esters thereof having a Tg<br>
lower than 0°C and wherein the free carboxy groups are salified with<br>
20 compatible organic or inorganic bases.<br>
The copolymers that can be used according to the invention consist of<br>
two or more monomers in various percentages.<br>
Examples of said monomers comprise:<br>
• acrylic acid<br>
25 • butyl acrylate<br>
• 2-ethylhexyl acrylate<br>
• glycidyl methacrylate<br>
• 2-hydroxyethyl acrylate<br>
• methyl acrylate<br>
• vinyl acetate<br>
• t-octylacrylamide<br>
Examples of copolymers according to the invention comprise poly(2-<br>
ethyl-hexyl acrylate-co-acrylic acid), poly(2-hydroxy-ethyl acrylate-co-<br>
acrylic acid -co-methyl-acrylates), poly(2-ethyl-hexyl acrylate-co-acrylic acid-<br>
co-methylacrylate), poly(2-ethyl-hexyl acrylate-co-acrylic acid-co-<br>
butilacrylate-co-vinyl acetate).<br>
These copolymers are commercially available with the following trade<br>
names: Duro-tak® (National and Starch), MG-0607® (Dow Corning),<br>
Gelva® (UCB chemicals), Luvimer® (BASF).<br>
These acrylic or methacrylic copolymers have a percentage of free<br>
carboxy groups of 0.1-15%, preferably 1-10%. Since they are not<br>
hot-extrudable, they are commercialised dissolved in organic solvents.<br>
The bases with which the carboxy groups are salified can be either<br>
inorganic, for example alkali, alkaline-earth or transition metals hydroxides,<br>
carbonates or bicarbonates, or organic, for example ammonia, ammonium<br>
methyl acrylates copolymers, ethylenediamine, lysine.<br>
The matrices of the invention further comprise from 0.1 to 20% by<br>
weight of water, preferably 1 to 5%.<br>
The invention allows to formulate any active ingredient having<br>
therapeutical, dermatological or cosmetic activity when administered through<br>
topical and/or transdermal route.<br>
Examples of medicaments which can be advantageously formulated<br>
according to the invention comprise: non steroidal antiinflammatory agents,<br>
corticosteroids, local anaesthetics, alpha-adrenergic agonists, analgesics,<br>
antimigraine drugs, anti-allergies, antihistaminics, antimicrobials, antiemetics,<br>
anticholinergics, bronchodilators, antivirals, myorelaxants, cholinergic agents,<br>
central nervous system stimulators, cardioactive agents, beta-adrenergic<br>
agonists, hormones, anxiolytics, antidepressants, antipsychotics, opioid<br>
antagonists, coronary dilators.<br>
Particularly preferred are non steroidal antiinflammatories such as<br>
Diclofenac, Fenoprofen, Flurbiprofen, Ibuprofen, Ibuproxam, Indoprofen,<br>
Ketoprofen, Ketorolac, Naproxen, Oxametacine, Oxyphenbutazone,<br>
Piroxicam, Suprofen, Celecoxib and other COX-2 selective inhibitors and the<br>
like.<br>
The matrices of the invention are particularly suitable as adhesive<br>
layers in transdermal patches.<br>
A further object of the invention is a process for the preparation of<br>
transdermal matrices which comprises the treatment of a copolymer having a<br>
Tg lower than 0°C and free carboxy groups suspended in an organic solvent<br>
with an aqueous solution of organic or inorganic bases in stoichiometric<br>
amounts in respect of the carboxylic groups, followed by addition of the active<br>
ingredient and any other excipients.<br>
By indicating Tg lower than 0°C, it is meant that the chosen polymeric solutions should<br>
be liquid at room temperature so that they could be easily handled being in liquid form. As<br>
polymeric blends are usually not strictly defined even by their manufacturer, Tg can vary for<br>
the real composition and the amount of solids.<br>
The organic solvents may be selected from ethyl acetate, IsopropanoL, methanol, toluene,<br>
hexane, heptane, which are the most representative solvents used in the manufacture of<br>
adhesive blends.<br>
Active ingredients are the ones, as indicated hereinbefore, in particular anti-<br>
inflammatories and antihypertensives.<br>
The matrices of the invention allow to improve the solubility, the<br>
stability and the diffusion of the active principle from the matrix.<br>
Detailed disclosure of the invention<br>
20 The polymeric matrix in the final formulation can be present in an<br>
amount ranging from 20 to 95%, preferably from 50 to 90%, based on the dry<br>
weight of the final composition.<br>
The acidic groups are neutralized with stoichiometric amounts of<br>
inorganic (alkali and transition metal hydroxides, e.g. sodium hydroxide,<br>
25 potassium hydroxide) or organic (e.g. ammonia, ammonium methyl acrylate<br>
copolymers, ethylenediamine, lysine) bases in the presence of a suitable amount<br>
of demineralised water to promote ion-exchange between the acidic groups of the<br>
polymeric structure and the basic counter-ion in a solvent system.<br>
Water is used in an amount that forms the solvatation sphere of the free<br>
ions without destabilizing the solvent system, so as to prevent precipitation of<br>
the polymer. The polymeric matrix, at first solvent-based, is transformed<br>
according to the invention into a solvent/water-based mixture. The amount of<br>
water ranges from 0.1 to 20%, preferably from 1 to 5% based on the wet<br>
weight of the adhesive mixture.<br>
In this way the acidic functions are neutralised and interactions with the<br>
active principle are avoided.<br>
The active principle dissolves completely at high concentrations in this<br>
system through synergistic interaction of the polymeric matrix, the solvent and<br>
the ion exchanges promoted by water protons. The amount of active principle<br>
incorporated in the system varies according to the nature of the active<br>
principle and the desired therapeutical effect.<br>
Usually, the amount of active principle ranges from 0.1 to 50%,<br>
preferably from 0.1 to 30% based on the dry weight of the final composition.<br>
After drying, the polymeric matrix that contains the active principle forms a<br>
controlled-release therapeutical system for the topical use. This matrix<br>
promotes the diffusion of the active principle, as the salification of the acidic<br>
groups in the polymeric chains makes the matrix structure more hydrophilic.<br>
The formulation can contain one or more excipients having different<br>
functions, for example skin-emollients, percutaneous permeation enhancers,<br>
preservatives and the like. The amount of each excipient varies within broad<br>
ranges, for example from 0.01 to 30%, and according to their action.<br>
Preservatives are usually comprised in the final formulation in amounts of<br>
0.01-2%, whereas emollients are comprised in the final formulation in<br>
amounts of 5-20%.<br>
The invention is illustrated in greater detail in the following examples.<br>
Example 1<br>
1 kg of Durotak® 87-2852 (poly(2-ethyl hexyl acrylate-co-acrylic acid-<br>
co-methyl acrylate)), having a solid content of 33.5% w/w, is added under<br>
mechanical stirring with 62 g of a 32% w/w potassium hydroxide aqueous<br>
solution; the mixture becomes more viscous and is left under moderate stirring<br>
for 30 min.<br>
Thereafter, 90 g of Diclofenac are added, and stirring is continued until<br>
complete dissolution.<br>
For the preparation of the matrix layer, the mixture is spread on a film<br>
of silicon polyester and the solvents are evaporated off in a static drier,<br>
heating at 60°C for 20 min. The spread matrix has a dry weight of about<br>
50 g/m2. After coupling to a polyethylene film, the patch is formed with a<br>
suitable punch.<br>
Example 2<br>
1 kg of Durotak® 87-2051 (poly(2-ethyl-hexyl acrylate-co-acrylic acid-<br>
co-butyl acrylate-co-vinyl acetate)), having a solid content of 51% w/w, is<br>
added under mechanical stirring with 64 g of a 32% w/w potassium hydroxide<br>
aqueous solution; the mixture becomes more viscous and is left under<br>
moderate stirring for 30 min.<br>
Thereafter, 90 g of Ketoprofen are added, and stirring is continued until<br>
complete dissolution.<br>
For the preparation of the matrix layer, the mixture is spread on a film of<br>
silicon polyester and the solvents are evaporated off in a static drier, heating at<br>
60°C for 20 min. The spread matrix has a dry weight of about 60 g/m2. After<br>
coupling to a polyethylene film, the patch is formed with a suitable punch.<br>
Example 3<br>
.1 kg of Durotak® 87-2852, having a content solid of 33.5% w/w, is<br>
added under mechanical stirring with 300 g of a 30%w/w Eudragit E100<br>
water/solvent-based solution; the mixture becomes more viscous and is left<br>
under moderate stirring for 30 min.<br>
Thereafter, 100 g of Diclofenac are added, and stirring is continued<br>
until complete dissolution.<br>
For the preparation of the matrix layer, the mixture is spread on a film<br>
of silicon polyester and the solvents are evaporated off in a static drier,<br>
heating at 60°C for 20 min. The spread matrix has a dry weight of about 60<br>
g/m2. After coupling to a polyethylene film, the patch is formed with a<br>
suitable punch.<br>
WE CLAIM:<br>
1. A polymeric matrix for the controlled release of medicaments for the topical transdermal<br>
use comprising copolymers of acrylic or methacrylic acid and/or esters thereof having a Tg lower<br>
than 0°C, wherein the free carboxy groups are salified with stoichiometric amounts of ammonia,<br>
ammonium methyl-acrylate copolymers, ethylenediamine, lysine.<br>
2. A matrix as claimed in claim 1, wherein the copolymers are selected from poly(2-ethyl-<br>
hexyl acrylate-co-acrylic acid), poly(2-hydroxy ethylacrylate-co- acrylic acid-co-methyl ac-<br>
rylates), poly(2-ethyl-hexyl acrylate-co-acrylic acid-co-methyl acrylates), poly(2-ethyl-hexyl ac-<br>
rylate-co-acrylic acid-co-butyl acrylate-co-vinyl acetate).<br>
3. A matrix as claimed in claim 1 or 2, wherein the acrylic or methacrylic copolymers have a<br>
percentage of free carboxy groups ranging from 0.1 to 15%.<br>
4. A matrix as claimed in claim 3, wherein the acrylic or methacrylic copolymers have a per-<br>
centage of free carboxy groups ranging from 1 to 10%.<br>
5. A matrix as claimed in any one of claims 1 to 4, containing 0.1 to 20% by weight of water.<br>
6. A matrix as claimed in claim 5, containing 1 to 5% by weight of water.<br>
7. A matrix as claimed in any one of claims 1 to 6, as adhesive layer in a transdermal patch.<br>
8. A process for the preparation of the matrices as claimed in any of claims 1 to 7, which process<br>
comprises the treatment of a copolymer having a Tg lower than 0°C and free carboxylic groups<br>
suspended in an organic solvent, such as herein described, with an aqueous solution of ammonia,<br>
ammonium methyl-acrylate copolymers, ethylenediamine, lysine in stoichiometric amounts in respect<br>
of the carboxylic groups, followed by addition of the active ingredient and any other excipients, such as<br>
herein described.<br><br><br><br>
Polymeric matrices for the controlled release of medicaments for the topical transdermal use comprising copolymers <br>
of acrylic and/or methacrylic acid or esters thereof having a Tg lower than 0°C, whose free carboxy groups are salified with<br>
compatible organic or inorganic bases. The matrices of the invention allow to prepare therapeutical systems for the controlled-release<br>
of active principles through the transdermal route, thus solving stability, solubility and/or bioavailability problems of the active<br>
ingredient within the matrix.<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0MTcta29sbnAtMjAwNy1hc3NpZ25tZW50LnBkZg==" target="_blank" style="word-wrap:break-word;">00417-kolnp-2007-assignment.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0MTcta29sbnAtMjAwNy1jbGFpbXMtMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">00417-kolnp-2007-claims-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0MTcta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZS0xLjEucGRm" target="_blank" style="word-wrap:break-word;">00417-kolnp-2007-correspondence-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDA0MTcta29sbnAtMjAwNy1pbnRlcm5hdGlvbmFsIHNlYXJjaCBhdXRob3JpdHkgcmVwb3J0LTEuMS5wZGY=" target="_blank" style="word-wrap:break-word;">00417-kolnp-2007-international search authority report-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LWFic3RyYWN0LnBkZg==" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LWNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LWNvcnJlc3BvbmRlbmNlIG90aGVycy5wZGY=" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-correspondence others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LWRlc2NyaXB0aW9uIChjb21wbGV0ZSkucGRm" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-description (complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LWZvcm0xLnBkZg==" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-form1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LWZvcm0zLnBkZg==" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-form3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LWZvcm01LnBkZg==" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-form5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LWludGVybmF0aW9uYWwgcHVibGljYXRpb24ucGRm" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-international publication.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LWludGVybmF0aW9uYWwgc2VhcmNoIGF1dGhvcml0eSByZXBvcnQucGRm" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-international search authority report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LXBjdCBmb3JtLnBkZg==" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-pct form.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQxNy1rb2xucC0yMDA3LXByaW9yaXR5IGRvY3VtZW50LnBkZg==" target="_blank" style="word-wrap:break-word;">0417-kolnp-2007-priority document.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctQUJTVFJBQ1QgMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-ABSTRACT 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctQU1BTkRFRCBDTEFJTVMucGRm" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-AMANDED CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctQVNTSUdOTUVOVC5wZGY=" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-ASSIGNMENT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctQ09SUkVTUE9OREVOQ0UucGRm" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctREVTQ1JJUFRJT04gKENPTVBMRVRFKSAxLjEucGRm" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-DESCRIPTION (COMPLETE) 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctRVhBTUlOQVRJT04gUkVQT1JUIFJFUExZIFJFQ0lFVkVELnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-EXAMINATION REPORT REPLY RECIEVED.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctRVhBTUlOQVRJT04gUkVQT1JULnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctRk9STSAxLTEuMS5wZGY=" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-FORM 1-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LWtvbG5wLTIwMDctZm9ybSAxOC5wZGY=" target="_blank" style="word-wrap:break-word;">417-kolnp-2007-form 18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctRk9STSAyLnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-FORM 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctRk9STSAzLTEuMS5wZGY=" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-FORM 3-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctRk9STSAzLnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctRk9STSA1LnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-FORM 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctR1BBLnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-GPA.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctR1JBTlRFRC1BQlNUUkFDVC5wZGY=" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-GRANTED-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctR1JBTlRFRC1DTEFJTVMucGRm" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-GRANTED-CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctR1JBTlRFRC1ERVNDUklQVElPTiAoQ09NUExFVEUpLnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-GRANTED-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctR1JBTlRFRC1GT1JNIDEucGRm" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-GRANTED-FORM 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctR1JBTlRFRC1GT1JNIDIucGRm" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-GRANTED-FORM 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctR1JBTlRFRC1TUEVDSUZJQ0FUSU9OLnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-GRANTED-SPECIFICATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctT1RIRVJTIDEuMS5wZGY=" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-OTHERS 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctT1RIRVJTLnBkZg==" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctUEEucGRm" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-PA.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctUEVUSVRJT04gVU5ERVIgUlVMRSAxMzcucGRm" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDctUkVQTFkgVE8gRVhBTUlOQVRJT04gUkVQT1JUIDEuMS5wZGY=" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007-REPLY TO EXAMINATION REPORT 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDE3LUtPTE5QLTIwMDcucGRm" target="_blank" style="word-wrap:break-word;">417-KOLNP-2007.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="250275-method-for-generating-foam-foam-and-foaming-material-prepared-by-the-said-method.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="250277-alkyl-pyridinium-dicyanamides-and-method-for-the-production-thereof.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>250276</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>417/KOLNP/2007</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>51/2011</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>23-Dec-2011</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>21-Dec-2011</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>05-Feb-2007</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>BOUTY S.P.A.</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>VIA VANVIETELLI, 4 I-20129, MILANO</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>STEFANELLI, PAOLA</td>
											<td>VIALE MONTENARO, 46 I-20135,MILANO</td>
										</tr>
										<tr>
											<td>2</td>
											<td>DI GRIGOLI, MAURIZIO</td>
											<td>VIA DEGLI ACERI ROSSI,5 I-20050 , VEDUGGIO CON COLZANO</td>
										</tr>
										<tr>
											<td>3</td>
											<td>ROMELLI, PIERBRUNO</td>
											<td>VIA PERFETTI, 1 I-20017, RHO</td>
										</tr>
										<tr>
											<td>4</td>
											<td>SCARSETTO, ALBERTO</td>
											<td>VIA PICASSO, 26, I-20092 CINISELLO BALSAMO</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K 9/70, A61K31/00</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP2005/007293</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2005-07-06</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>MI2004A 001628</td>
									<td>2004-08-06</td>
								    <td>Italy</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/250276-polymeric-adhesive-matrix-with-salified-carboxylic-groups-for-transdermal-use by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 14:31:42 GMT -->
</html>
